Asensus Surgical, Inc. (ASXC)
Aug 22, 2024 - ASXC was delisted (reason: acquired by KARL STORZ)
0.350
0.00 (0.00%)
Inactive · Last trade price
on Aug 21, 2024
Asensus Surgical Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Year Ending | TTM | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
| Revenue | 9.85 | 8.58 | 7.09 | 8.23 | 3.18 | 8.53 | Upgrade
|
| Revenue Growth (YoY) | 39.05% | 21.02% | -13.91% | 159.28% | -62.78% | -64.60% | Upgrade
|
| Cost of Revenue | 12.85 | 13.16 | 10.87 | 11.1 | 5.17 | 13.33 | Upgrade
|
| Gross Profit | -3 | -4.58 | -3.79 | -2.86 | -1.99 | -4.8 | Upgrade
|
| Selling, General & Admin | 34.15 | 36.08 | 34.93 | 32.72 | 27.2 | 46.77 | Upgrade
|
| Research & Development | 33.63 | 37.02 | 28.94 | 19.35 | 16.62 | 22.47 | Upgrade
|
| Operating Expenses | 68.22 | 73.55 | 71.58 | 63.32 | 54.62 | 79.54 | Upgrade
|
| Operating Income | -71.22 | -78.13 | -75.36 | -66.18 | -56.61 | -84.34 | Upgrade
|
| Interest Expense | -0.32 | - | -0.41 | -0.37 | -0.02 | -3.61 | Upgrade
|
| Interest & Investment Income | 0.88 | 1.55 | 1.14 | 0.59 | 0.04 | 0.58 | Upgrade
|
| Other Non Operating Income (Expenses) | 0.44 | -0.2 | -0.3 | -2 | -0.46 | 1.28 | Upgrade
|
| EBT Excluding Unusual Items | -70.23 | -76.78 | -74.93 | -67.96 | -57.05 | -86.09 | Upgrade
|
| Merger & Restructuring Charges | - | - | - | - | -0.85 | -8.77 | Upgrade
|
| Impairment of Goodwill | - | - | - | - | - | -78.97 | Upgrade
|
| Gain (Loss) on Sale of Assets | - | - | - | - | - | 15.87 | Upgrade
|
| Asset Writedown | -0.37 | -0.37 | -1.43 | - | - | - | Upgrade
|
| Other Unusual Items | -12.84 | -0.96 | 1.12 | 5.72 | -2.92 | 8.55 | Upgrade
|
| Pretax Income | -83.44 | -78.12 | -75.24 | -62.24 | -60.83 | -157.33 | Upgrade
|
| Income Tax Expense | 0.36 | 0.31 | 0.32 | 0.23 | -1.52 | -3.12 | Upgrade
|
| Net Income | -83.8 | -78.43 | -75.56 | -62.46 | -59.31 | -154.2 | Upgrade
|
| Preferred Dividends & Other Adjustments | - | - | - | - | 0.71 | - | Upgrade
|
| Net Income to Common | -83.8 | -78.43 | -75.56 | -62.46 | -60.02 | -154.2 | Upgrade
|
| Shares Outstanding (Basic) | 266 | 250 | 236 | 227 | 71 | 18 | Upgrade
|
| Shares Outstanding (Diluted) | 266 | 250 | 236 | 227 | 71 | 18 | Upgrade
|
| Shares Change (YoY) | 11.67% | 5.58% | 4.20% | 220.52% | 299.22% | 11.29% | Upgrade
|
| EPS (Basic) | -0.32 | -0.31 | -0.32 | -0.28 | -0.85 | -8.69 | Upgrade
|
| EPS (Diluted) | -0.32 | -0.31 | -0.32 | -0.28 | -0.85 | -8.69 | Upgrade
|
| Free Cash Flow | -57.16 | -64.19 | -60.22 | -42.03 | -46.68 | -73.92 | Upgrade
|
| Free Cash Flow Per Share | -0.22 | -0.26 | -0.25 | -0.19 | -0.66 | -4.17 | Upgrade
|
| Gross Margin | -30.45% | -53.38% | -53.41% | -34.79% | -62.71% | -56.27% | Upgrade
|
| Operating Margin | -723.08% | -910.92% | -1063.40% | -803.98% | -1783.12% | -988.64% | Upgrade
|
| Profit Margin | -850.75% | -914.46% | -1066.19% | -758.77% | -1890.49% | -1807.54% | Upgrade
|
| Free Cash Flow Margin | -580.27% | -748.37% | -849.67% | -510.53% | -1470.17% | -866.50% | Upgrade
|
| EBITDA | -67.47 | -74.4 | -64.29 | -52.07 | -42.92 | -71.87 | Upgrade
|
| D&A For EBITDA | 3.76 | 3.73 | 11.08 | 14.11 | 13.7 | 12.47 | Upgrade
|
| EBIT | -71.22 | -78.13 | -75.36 | -66.18 | -56.61 | -84.34 | Upgrade
|
| Revenue as Reported | 9.85 | 8.58 | 7.09 | 8.23 | 3.18 | 8.53 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.